Abstract
Background/Aims: The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor afatinib is primarily utilized for the treatment of non-small c......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
